Abridge, a Pittsburgh, PA-based generative AI platform for clinical conversations, has raised $250 million in Series D funding.
Investors
The round was co-led by Elad Gil and IVP, with participation from Bessemer Venture Partners, California Health Care Foundation, CapitalG, CVS Health Ventures, K. Ventures, Lightspeed Venture Partners, NVentures (NVIDIA’s venture arm), Redpoint Ventures, Spark Capital, and SV Angel.
Elad Gil is a well-known entrepreneur, angel investor, and advisor that invests in various startups, particularly in sectors such as technology, healthcare, and artificial intelligence (AI)
IVP (Institutional Venture Partners) is a venture capital and growth equity firm based in the United States, primarily investing in late-stage and growth-stage technology companies across various sectors, including software, fintech, health tech, and consumer technology.
Abridge Use of Funds
The investment will fuel further development of AI capabilities and support commercial growth for broader applications.
About Abridge
Founded in 2018, Abridge provides a generative AI platform for healthcare to assist clinicians in medical conversations. The company’s AI technology converts patient-clinician conversations into structured, billable documentation in real time. Supporting over 28 languages and over 50 specialties, Abridge is used across diverse care settings, including outpatient clinics, emergency departments, and inpatient care. The platform is deployed in over 100 major U.S. healthcare systems, ranging from rural hospitals to top academic centers.
Funding Details
Company: Abridge AI, Inc.
Raised: $250.0M
Round: Series D
Funding Date: February 2025
Lead Investors: Elad Gil, IVP
Additional Investors: Bessemer Venture Partners, California Health Care Foundation, CapitalG, CVS Health Ventures, K. Ventures, Lightspeed Venture Partners, NVentures, Redpoint Ventures, Spark Capital, SV Angel
Company Website: https://www.abridge.com/
Software Category: Healthcare Communication and Documentation
Source: https://www.abridge.com/press-release/series-d